Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions. Founded by Nicholas Opie and Thomas Oxley in 2016, Synchron is backed by investors that include Khosla Ventures, Neurotechnology Investors, DARPA, Shanda Group, and re.Mind Capital and is headquartered in Campbell.
FOUNDED:
2016
INDUSTRY:
Manufacturing, Marketing, Medical Device
FOUNDERS:
Nicholas Opie, Thomas Oxley
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
